Login / Signup

Concerns, Healthcare Use, and Treatment Interruptions in Patients With Common Autoimmune Rheumatic Diseases During the COVID-19 Pandemic.

Michael D GeorgeShilpa VenkatachalamShubhasree BanerjeeJoshua F BakerPeter A MerkelKelly GaviganDavid CurtisMaria I DanilaJeffrey R CurtisWilliam Benjamin Nowell
Published in: The Journal of rheumatology (2020)
In the early months of the COVID-19 pandemic, patients with RA, PsA, AS, and SLE frequently avoided office visits and laboratory testing. DMARD interruptions commonly occurred without the advice of a physician and were associated with SES, office visits, and telehealth availability, highlighting the need for adequate healthcare access and attention to vulnerable populations during the pandemic.
Keyphrases